Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®: Complete Statistical AnalysisIndependent statistical analysis of Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Retrospective Encore Reverse Shoulder Prosthesis Study: Complete Statistical AnalysisIndependent statistical analysis of Retrospective Encore Reverse Shoulder Prosthesis Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00765037).
- Retrospective Evaluation of Performance of Coflex® Interlaminer Technology Versus Decompression With or Without Fusion: Complete Statistical AnalysisIndependent statistical analysis of Retrospective Evaluation of Performance of Coflex® Interlaminer Technology Versus Decompression With or Without Fusion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Retrospective Observational Study To Update 5-Year Survival Of Subjects Who Participated In Axitinib Trial A4061012: Complete Statistical AnalysisIndependent statistical analysis of Retrospective Observational Study To Update 5-Year Survival Of Subjects Who Participated In Axitinib Trial A4061012: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Retrospective Post-Market Clinical Follow-Up Study of GORE-TEX® Vascular Grafts and GORE® PROPATEN® Vascular Graft in Peripheral Artery Disease, Aortic Aneurysms, and Dialysis Access: Complete Statistical AnalysisIndependent statistical analysis of Retrospective Post-Market Clinical Follow-Up Study of GORE-TEX® Vascular Grafts and GORE® PROPATEN® Vascular Graft in Peripheral Artery Disease, Aortic Aneurysms, and Dialysis Access: primary endpoint results, effect estimate…
- Retrospective Study Chimaera Long Nail in Adult Patient: Complete Statistical AnalysisIndependent statistical analysis of Retrospective Study Chimaera Long Nail in Adult Patient: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06285981).
- Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions: Complete Statistical AnalysisIndependent statistical analysis of Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Retrospective Study on Referral Patterns for High Risk Patients Post Nephrectomy: Complete Statistical AnalysisIndependent statistical analysis of Retrospective Study on Referral Patterns for High Risk Patients Post Nephrectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- RetroTIFIndependent statistical analysis of Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Return of First-phase Insulin Secretion in Type 2 Diabetes is Associated With Depletion of Pancreas Lipid: Complete Statistical AnalysisIndependent statistical analysis of Return of First-phase Insulin Secretion in Type 2 Diabetes is Associated With Depletion of Pancreas Lipid: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- rev/abraxaneIndependent statistical analysis of Phase I/II Trial of the Combination of Lenalidomide (Revlimid) and Nab-paclitaxel (Abraxane) in the Treatment of Relapsed/Refractory Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size…
- Revaccination With Influenza Vaccine GSK1247446A: Complete Statistical AnalysisIndependent statistical analysis of Revaccination With Influenza Vaccine GSK1247446A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00545025).
- Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007): Complete Statistical AnalysisIndependent statistical analysis of Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00560950).
- REVEALIndependent statistical analysis of Evaluation of AMG 714 for Vitiligo: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04338581).
- REVEALIndependent statistical analysis of REVEAL III: Risk Evaluation and Education for Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00462917).
- REVEALIndependent statistical analysis of REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01252953).
- REVEALIndependent statistical analysis of Revolution™ Peripheral Atherectomy System for Lower Extremity Peripheral Arterial Revascularization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02961894).
- REVEAL 1Independent statistical analysis of REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Reveal In-Office Implants: Complete Statistical AnalysisIndependent statistical analysis of Reveal In-Office Implants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01168427).
- Reveal LINQ for Chronic Obstructive Pulmonary Disease (COPD): Complete Statistical AnalysisIndependent statistical analysis of Reveal LINQ for Chronic Obstructive Pulmonary Disease (COPD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04169529).
- REVEALPLAQUEIndependent statistical analysis of The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- REVELUTIONIndependent statistical analysis of RElugolix VErsus LeUprolide Cardiac Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05320406).
- Reversal of Dabigatran Anticoagulant Effect With Idarucizumab: Complete Statistical AnalysisIndependent statistical analysis of Reversal of Dabigatran Anticoagulant Effect With Idarucizumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02104947).
- Reversal of Hepatic Impairment in Patients With Hepatitis C Virus (HCV) and Early Decompensation of Cirrhosis: Complete Statistical AnalysisIndependent statistical analysis of Reversal of Hepatic Impairment in Patients With Hepatitis C Virus (HCV) and Early Decompensation of Cirrhosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- REVERSEIndependent statistical analysis of Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Reverse Medical Barrel™ Device for Adjunctive Treatment for Wide-Neck, Intracranial, Bifurcating/Branching Aneurysms: Complete Statistical AnalysisIndependent statistical analysis of Reverse Medical Barrel™ Device for Adjunctive Treatment for Wide-Neck, Intracranial, Bifurcating/Branching Aneurysms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib: Complete Statistical AnalysisIndependent statistical analysis of Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01466972).
- Reversing Synchronized Brain Circuits With Targeted Auditory-Somatosensory Stimulation to Treat Phantom Percepts: Complete Statistical AnalysisIndependent statistical analysis of Reversing Synchronized Brain Circuits With Targeted Auditory-Somatosensory Stimulation to Treat Phantom Percepts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Reversing Ticagrelor’s Effects With Fresh Platelets: Complete Statistical AnalysisIndependent statistical analysis of Reversing Ticagrelor's Effects With Fresh Platelets: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02201394).
- REVIRAL 1Independent statistical analysis of A Study to Learn About the Effects of Sisunatovir in Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection.: primary endpoint results, effect estimate with confidence interval, sample-size…
- Revitalize Cognition: Near Infrared Stimulation in Older Adults: Complete Statistical AnalysisIndependent statistical analysis of Revitalize Cognition: Near Infrared Stimulation in Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02582593).
- Revlimid in Transfusion Dependent Patients: Complete Statistical AnalysisIndependent statistical analysis of Revlimid in Transfusion Dependent Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01178814).
- Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01600053).
- Reward Function and Therapy for Late-Life Depression: Complete Statistical AnalysisIndependent statistical analysis of Reward Function and Therapy for Late-Life Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03688139).
- Reward Processes and Rehearsal in Exposure Therapy: Complete Statistical AnalysisIndependent statistical analysis of Reward Processes and Rehearsal in Exposure Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06132425).
- Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 Pandemic: Complete Statistical AnalysisIndependent statistical analysis of Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 Pandemic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RHA® 4 NLF Cannula: Complete Statistical AnalysisIndependent statistical analysis of RHA® 4 NLF Cannula: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04754646).
- RHA® Redensity Eye Versus No-treatment for the Infra-Orbital Hollows: Complete Statistical AnalysisIndependent statistical analysis of RHA® Redensity Eye Versus No-treatment for the Infra-Orbital Hollows: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04577898).
- RHA® Redensity With New Anesthetic Agent – Perioral Rhytids: Complete Statistical AnalysisIndependent statistical analysis of RHA® Redensity With New Anesthetic Agent - Perioral Rhytids: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04069585).
- RHAPSODYIndependent statistical analysis of Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Rheos® Pivotal Trial: Complete Statistical AnalysisIndependent statistical analysis of Rheos® Pivotal Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00442286).
- RHINEIndependent statistical analysis of A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- RHINTRACIndependent statistical analysis of RhinAer Procedure for Treatment of Chronic Rhinitis Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04533438).
- Rhodiola Rosea Therapy of Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of Rhodiola Rosea Therapy of Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01098318).
- Rhythm-based Intervention in Aphasia: Complete Statistical AnalysisIndependent statistical analysis of Rhythm-based Intervention in Aphasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04581564).
- Ri-CoDIFy 1Independent statistical analysis of Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03595553).
- Ri-CoDIFy 3Independent statistical analysis of Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04802837).
- RI-US XLIndependent statistical analysis of Resolute Integrity US Extended Length Sub-Study(RI US XL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01913600).
- RIAIndependent statistical analysis of Induction FOLFOX With or Without Aflibercept Followed by Chemoradiation in High Risk Locally Advanced Rectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- RibFxIndependent statistical analysis of Orthosis of Acute Traumatic Rib Fractures Via RibFx Belt for Pain Alleviation and Improved Pulmonary Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…